Operation Warp Speed Spreads Its Bets With $1.6bn Novavax Deal

Biggest Award Yet, But Strategy Remains Unclear

 
• By Andrew McConaghie
  
Novavax
Novavax's recombinant protein nanoparticle vaccine offers an alternative approach to Moderna and AstraZeneca
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip